Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Thursday - 8 September 2022

Thursday, 8 September 2022

Questions (1686)

David Cullinane

Question:

1686. Deputy David Cullinane asked the Minister for Health further to Parliamentary Question No. 1629 of 26 July 2022, if there are no avenues for a dispenser-supplier, outside of the prescribed manufacturer-suppliers set in Schedule 3 of the HSE-IPHA Framework Agreement (2021) to apply or otherwise petition for the inclusion of a medicine or appliance on the long-term illness scheme; the reason there are any means by which a medical doctor, pharmacist, or other licensed prescriber may petition for the inclusion of a product on such schemes and reimbursement lists; and if he will make a statement on the matter. [42670/22]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Top
Share